{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:54:01Z","timestamp":1790967241452,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.urology.2008.08.459","type":"journal-article","created":{"date-parts":[[2008,11,9]],"date-time":"2008-11-09T04:23:26Z","timestamp":1226204606000},"page":"363-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["PCA3 Urine mRNA Testing for Prostate Carcinoma: Patterns of Use by Community Urologists and Assay Performance in Reference Laboratory Setting"],"prefix":"10.1016","volume":"73","author":[{"given":"Scott B.","family":"Shappell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Arguello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew J.","family":"Putzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2008.08.459_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ucl.2004.01.002","article-title":"Screening for prostate cancer: Current recommendations","volume":"31","author":"Wilson","year":"2004","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2008.08.459_bib2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.soc.2005.07.001","article-title":"Screening for prostate cancer: Opportunities and challenges","volume":"14","author":"Thompson","year":"2005","journal-title":"Surg Oncol Clin North Am"},{"key":"10.1016\/j.urology.2008.08.459_bib3","first-page":"44","article-title":"Clinical utility of prostate carcinoma molecular diagnostic tests","volume":"10","author":"Shappell","year":"2008","journal-title":"Rev Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib4","first-page":"5975","article-title":"DD3: A new prostate-specific gene, highly overexpressed in prostate cancer","volume":"59","author":"Bussemakers","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2008.08.459_bib5","first-page":"2695","article-title":"DD3PCA3, a very sensitive and specific marker to detect prostate tumors","volume":"62","author":"de Kok","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2008.08.459_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","article-title":"DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer","volume":"44","author":"Hessels","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.eururo.2004.06.004","article-title":"DD3(PCA3) RNA analysis in urine\u2014A new perspective for detecting prostate cancer","volume":"46","author":"Tinzl","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.urology.2004.03.052","article-title":"uPM3, a new molecular urine test for the detection of prostate cancer","volume":"64","author":"Fradet","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.08.459_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.urology.2008.08.459_bib10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/1078-0432.CCR-06-2679","article-title":"The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance","volume":"13","author":"van Gils","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2008.08.459_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.08.459_bib12","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/S0022-5347(01)62200-6","article-title":"Nonpalpable stage T1c prostate cancer: Prediction of insignificant disease using free\/total prostate specific antigen levels and needle biopsy findings","volume":"160","author":"Epstein","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: A molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib14","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.juro.2008.01.013","article-title":"PCA3 molecular urine assay correlates with prostate cancer tumor volume: Implication in selecting candidates for active surveillance","volume":"179","author":"Nakanishi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(05)00337-X","article-title":"Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: Implications for patient care","volume":"175","author":"Epstein","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-5347(05)00338-1","article-title":"Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: Implications for cancer detection and biopsy strategy","volume":"175","author":"Girasole","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0094-0143(02)00188-X","article-title":"When to biopsy and when to stop biopsying","volume":"30","author":"Djavan","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2008.08.459_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ncpuro0887","article-title":"Prostate biopsy strategies","volume":"4","author":"Presti","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.juro.2007.05.016","article-title":"Pathological features after radical prostatectomy in potential candidates for active monitoring","volume":"178","author":"Griffin","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.08.459_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/modpathol.3800963","article-title":"Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization","volume":"20","author":"Popa","year":"2007","journal-title":"Mod Pathol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429508014313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429508014313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:49:02Z","timestamp":1758764942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429508014313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0090429508014313"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2008.08.459","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCA3 Urine mRNA Testing for Prostate Carcinoma: Patterns of Use by Community Urologists and Assay Performance in Reference Laboratory Setting","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2008.08.459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}